Charles River Labs Intl buy Barclays PLC
Start price
02.10.25
/
50%
€149.30
Target price
02.10.26
€166.12
Performance (%)
1.11%
Price
03.10.25
€150.95
Summary
This prediction is currently active. The BUY prediction by Barclays_PLC shows slight gains of 1.11%. This prediction currently runs until 02.10.26. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Charles River Labs Intl | 1.11% |
iShares Core DAX® | 2.709% |
iShares Nasdaq 100 | 0.867% |
iShares Nikkei 225® | 3.135% |
iShares S&P 500 | 0.886% |
Comments by Barclays_PLC for this prediction
In the thread Charles River Labs Intl diskutieren
Charles River Laboratories International (NYSE:CRL) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating. They now have a $195.00 price target on the stock, up previously from $165.00.
Ratings data for CRL provided by MarketBeat